Morris + Stoltz LLP welcomes Michael Hodgins
Morris + Stoltz LLP is pleased to announce that Michael Hodgins has joined the Firm as an associate.
June 25, 2026
Associate announcement
Smart & Biggar is pleased to welcome Aleksandra (Sasha) Gracia to the Ottawa office as an associate in our life sciences practice group.
September 20, 2018
Aleksandra (Sasha) Gracia‘s practice focuses on securing patent protection for pharmaceutical, biotechnology, and other inventions in life sciences. She brings deep technical expertise in biochemistry, microbiology and immunology to her work with clients in the biotechnology and pharmaceutical industries. She also works in the area of pharmaceutical regulatory law, providing strategic advice both during and after patent prosecution for pharmaceuticals and biologics.
Aleksandra received her Bachelor of Science degree in Biochemistry and Microbiology from the University of Victoria. During her graduate studies, she participated in the Vaccine & Infectious Disease Organization’s (VIDO) – International Vaccine Centre (InterVac) Neonatal Immunization Group. At VIDO, with funding from the Bill & Melinda Gates Foundation, she assisted in the development of a new vaccine adjuvant platform for use in the immunization of infants in developing countries. Aleksandra completed her doctorate degree in Immunology & Vaccinology while enrolled in her second year of law school, both at the University of Saskatchewan.
Smart & Biggar is widely recognized as Canada’s leading intellectual property firm. We are leaders in intellectual property and have been serving clients for over a century. Smart & Biggar operates as part of the IPH Limited group, under its own brand and independent from other IPH member firms.
View All Announcements by This Firm
Morris + Stoltz LLP is pleased to announce that Michael Hodgins has joined the Firm as an associate.
June 25, 2026
Gluckstein Lawyers is excited to welcome Naomi Richardson as an Associate.
June 25, 2026
Gluckstein Lawyers is pleased to welcome Cynthia Rizzo to our Medical Malpractice Team as an Associate.
June 25, 2026